3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside has been researched along with zidovudine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amblard, F; Asif, G; Bondada, L; Coats, SJ; Detorio, M; Fromentin, E; Mellors, JW; Obikhod, A; Schinazi, RF; Sluis-Cremer, N; Solomon, S; Whitaker, T; Zhang, HW | 1 |
Harada, Y; Liu, X; Mizushina, Y; Ogawara, T; Ogimura, Y; Saneyoshi, M; Takahashi, H; Yamaguchi, T | 1 |
2 other study(ies) available for 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside and zidovudine
Article | Year |
---|---|
Synthesis and evaluation of 3'-azido-2',3'-dideoxypurine nucleosides as inhibitors of human immunodeficiency virus.
Topics: Anti-HIV Agents; Dideoxynucleosides; Glycosylation; HIV Reverse Transcriptase; Humans; Lymphocytes | 2010 |
3'-Azido-2',3'-dideoxynucleoside 5'-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cells.
Topics: Antineoplastic Agents; Cell Proliferation; Dideoxyadenosine; Dideoxynucleosides; Dideoxynucleotides; DNA; Enzyme Inhibitors; HeLa Cells; HL-60 Cells; Humans; Telomerase; Telomere; Zidovudine | 2007 |